Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Compensatory Hyperinsulinemia

3,4-dihydroxyphenylacetic acid has been researched along with Compensatory Hyperinsulinemia in 2 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bello, NT1
Hajnal, A2
Lénárd, L1

Other Studies

2 other studies available for 3,4-dihydroxyphenylacetic acid and Compensatory Hyperinsulinemia

ArticleYear
Alterations in blood glucose levels under hyperinsulinemia affect accumbens dopamine.
    Physiology & behavior, 2006, Jun-15, Volume: 88, Issue:1-2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Blood Glucose; Brain Chemistry; Dopam

2006
Feeding-related dopamine in the amygdala of freely moving rats.
    Neuroreport, 1997, Aug-18, Volume: 8, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Dopamine; Feeding Behavior; Food Deprivation; Hom

1997